✦ LIBER ✦

PCN110 COST-MINIMIZATION ANALYSIS OF XELOX VERSUS FOLFOX ± BEVACIZUMAB FOR TREATMENT OF METASTATIC COLORECTAL CANCER (MCRC) IN SAUDI ARABIAN HOSPITAL SETTING

✍ Scribed by AS Zazaa; H AlOmar; SA El-Moursy; M AlFayyadh

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PCN38 COST-ANALYSIS OF XELOXVS. FOLFOX-4

✍ LP Garrison; G Giuliani; P Ducournau; A Cirrincione 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 75 KB

PCN46 COST-MINIMIZATION ANALYSIS OF CAPE

✍ MG Saggia; VD Nasciben; EA Santos; S Stefani 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB

PCN26 A COST-EFFECTIVENESS ANALYSIS OF X

✍ J Darba; G Restovic; A Ramírez de Arellano 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB

EC3 COST-MINIMIZATION ANALYSIS OF CAPECI

✍ G Perrocheau; M Ducreux; M Hebbar; M Ychou; G Lledo; T Conroy; R Faroux; JY Doui 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 73 KB